By Erica Teichert
Daiichi Sankyo announced it will recall 13 lots in Japan of a Sanofi Pasteur ActHIB vaccine–whose use has been suspended in the country–due to an unidentified substance found in two syringes. Japan officials have cleared the vaccine, and Pfizer’s Prevnar, after investigating the vaccines’ role in six children’s deaths.
Leave a Reply